Opiate Craving Reduction Study Using Post-detox Patients on Suboxone and Use of TEAS as Adjunctive Treatment

- this crossover study will involve participants who will be randomized into two treatment
groups,A&B. TEAS treatments will be given for 30 minutes,X2/week,for 6 weeks(12total
sessions). Group A will receive 2 weeks(4 sessions) of active treatment followed by 4
weeks of sham treatment(8 sessions). Group B will receive 2 weeks(4 sessions) of sham
treatment,2 weeks (4 sessions)of real treatment,and finally 2 weeks (4 sessions) of sham
treatment.

- parameters to be measured include vital signs and questionnaires weeks 1,3,5,6 to assess
self-reported past 14-day substance use,alcohol and drug craving,withdrawal
symptoms,sleep,mood,pain and overall quality of life.

- goals include better lives for post-detox opiate addicts as they incorporate this
treatment into their lives,saving themselves and loved ones more horror,and their
communities resources.

Inclusion Criteria:

- 18-59 years old

- early recovery(0-3months of abstinence

- not currently detoxing

- maintained on buprenorphine-naloxone under the care of qualified MD

- proficient in the English language

Exclusion Criteria:

- having acute,psychiatric symptoms which would pose safety concerns,or an adherence to
treatment barrier(active suicidality/psychosis/mania)

- severe cognitive disorders*not competent to give informed consent

- active cardiac disease or EKG abnormalities or with cardiac pacemaker

- currently detoxing from alcohol or illicit drugs

- inability or non-intention to attend all treatment sessions*history of
seizures*pregnancy or breast feeding.